Polymersomes-based curcumin delivery as cancer therapeutics
Carregando...
Arquivos
Fontes externas
Fontes externas
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Capítulo de livro
Direito de acesso
Arquivos
Fontes externas
Fontes externas
Resumo
Curcumin (CUR) is a phenolic molecule with yellow color and high bioactive capacity present in certain herbs and in particular found in turmeric rhizomes (including Curcuma longa Linn.). In addition to being used as a spice in several cultures, CUR has already established itself in the pharmaceutical field with several beneficial properties, such as antioxidant, antiinflammatory, and antimicrobial. Interestingly, CUR has immense antitumor activity, but its efficiency is limited due to some properties (e.g., low solubility, chemical instability, and reduced in vivo absorption rate). Nanostructures have been employed to surpass these challenges. In this way, polymersomes (PSs), which are nanostructures formed by self-assembling, are able to encapsulate hydrophilic and hydrophobic drugs simultaneously (or individually). PSs also have good encapsulation rates, robustness, and stealth capability, which result in low immunogenicity. This chapter overviews the literature on the encapsulation of CUR into PSs, focusing on its employment and effectiveness in cancer therapy.
Descrição
Palavras-chave
amphiphilic block copolymers (ABC), cancer therapy, chemotherapeutic agent, curcumin (CUR), nanostructures, Polymersomes (PSs), self-assembly, tumor cells
Idioma
Inglês
Citação
Curcumin-Based Nanomedicines as Cancer Therapeutics, p. 291-305.




